Cargando…
Second-line rescue treatment of Helicobacter pylori infection: Where are we now?
At present, the best rescue therapy for Helicobacter pylori (H. pylori) infection following failure of first-line eradication remains unclear. The Maastricht V/Florence Consensus Report recommends bismuth quadruple therapy, or fluoroquinolone-amoxicillin triple/quadruple therapy as the second-line t...
Autores principales: | Lin, Te-Fu, Hsu, Ping-I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209570/ https://www.ncbi.nlm.nih.gov/pubmed/30386104 http://dx.doi.org/10.3748/wjg.v24.i40.4548 |
Ejemplares similares
-
Helicobacter pylori in humans: Where are we now?
por: Hussain, Syed Arshad, et al.
Publicado: (2014) -
Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004) -
Update on quinolone-containing rescue therapies for Helicobacter pylori infection
por: Mori, Hideki, et al.
Publicado: (2020) -
Role of endoscopic ultrasound in vascular interventions: Where are we now?
por: Fugazza, Alessandro, et al.
Publicado: (2022) -
Esophagogastric junction outflow obstruction: Where are we now in diagnosis and management?
por: Samo, Salih, et al.
Publicado: (2019)